An IGF-binding protein, IBP-5 is produced by fibroblasts, myoblasts, osteoblasts and vascular smooth muscle cells. IBP-5 has been shown to specifically inhibit breast cancer cell growth by inducing apoptosis. IBP-5 contains an IGFBP domain and a thyroglobulin type-1 domain.